Pyoderma gangrenosum

First-line therapies
Second-line therapies
Third-line therapies
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Br J Dermatol 2009; 161: 1199–201.
A single case of PG associated with an autosomal dominant genodermatosis.
A case of PG associated with inflammatory bowel disease has been reported not to respond.